Insider Transactions in Q4 2025 at Collegium Pharmaceutical, Inc (COLL)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 12
2025
|
Vikram Karnani President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,983
-8.48%
|
$422,201
$47.35 P/Share
|
|
Nov 12
2025
|
John A. Fallon |
SELL
Open market or private sale
|
Direct |
34,853
-35.03%
|
$1,638,091
$47.21 P/Share
|
|
Nov 12
2025
|
John A. Fallon |
BUY
Exercise of conversion of derivative security
|
Direct |
34,853
+16.24%
|
$418,236
$12.91 P/Share
|
|
Nov 06
2025
|
Colleen Tupper EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
30,000
-9.87%
|
$1,200,000
$40.83 P/Share
|